PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia
Conditions: Tuberculosis; HIV Intervention: Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2021 Category: Research Source Type: clinical trials
Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries
DiscussionThe PREVAC trial is evaluating —placebo-controlled—two promising Ebola candidate vaccines in advanced stages of development. The results will address unanswered questions related to short- and long-term safety and immunogenicity for three vaccine strategies in adults and children.Trial registrationClinicalTrials.govNCT02876328. Registered on 23 August 2016. (Source: Trials)
Source: Trials - January 23, 2021 Category: Research Source Type: clinical trials
Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia
Condition: Malaria Intervention: Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2021 Category: Research Source Type: clinical trials
